Tryptamine Therapeutics Begins Phase 2a Trial for IBS Treatment at MGH

By Proactive Investors / July 25, 2024 / www.youtube.com / Article Link


Tryptamine Therapeutics Ltd (ASX: TYP) president and chief scientific officer Jim Gilligan joins Jonathan Jackson in the Proactive ...

Recent News

China's gold holdings to central bank reserves still low
September 30, 2024 / www.canadianminingreport.com

China has broad effect on gold market
September 30, 2024 / www.canadianminingreport.com

Gold stocks mixed after previous week's huge gains
September 23, 2024 / www.canadianminingreport.com

Large TSXV gold multiple driven up by high Artemis weighting
September 23, 2024 / www.canadianminingreport.com

Monetary-driven precious metals outperform major base metals
September 09, 2024 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok